Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: hospital

U.S. & Europe Evaluate Abaloparatide Injection & Europe Approves Marketing Baricitinib for RA

Michele B. Kaufman, PharmD, BCGP  |  April 11, 2017

Injectable abaloparatide is being evaluated in the U.S. and Europe to treat postmenopausal women with osteoporosis…

Filed under:ConditionsDrug UpdatesOsteoarthritis and Bone Disorders Tagged with:abaloparatidebaricitinibJanus Kinase InhibitorsOsteoporosispostmenopauseWomen

CORC: The Uncomfortable Move from Fee for Service to Value

Doug White, MD  |  April 4, 2017

ACR members are spread out across the U.S., but we all work in the same place: the land of fee for service. FFS, as it’s known to policy nerds, poses certain problems for cognitive subspecialists like rheumatologists. For instance, much of the work we do—calling providers and patients, coordinating care after hours—often isn’t compensated. And…

Filed under:Billing/CodingFrom the CollegePractice Support

Sirukumab Promising for RA

Michele B. Kaufman, PharmD, BCGP  |  April 4, 2017

In a clinical trial, RA patients on sirukumab experienced decreased disease activity and improved physical function…

Filed under:Drug Updates Tagged with:Rheumatoid Arthritis (RA)sirukumab

Do You Have What It Takes to Be an Educator?

Karen Appold  |  April 3, 2017

Two rheumatologists share why they became educators, the challenges they face and what keeps them teaching young physicians…

Filed under:Career DevelopmentEducation & TrainingProfessional Topics Tagged with:Educationmedical teachingMentoringteacherteaching

Recommendations for Sjögren’s Syndrome: How to Address Biologics & Musculoskeletal Pain

Arthritis Care & Research  |  April 2, 2017

The clinical practice guidelines for managing Sjögren’s syndrome, developed by the Sjögren’s Syndrome Foundation with the ACR, were designed to improve quality and consistency of care. In total, 19 recommendations were agreed on, which include managing the rheumatic and systemic aspects of the disease. Recommendations include a decision tree for the use of DMARDs for inflammatory musculoskeletal pain, use of self-care measures and exercise to reduce fatigue, and the use of rituximab in selected clinical settings for oral and ocular dryness…

Filed under:ConditionsResearch RheumSjögren’s Disease Tagged with:Arthritis Care & ResearchClinical Practice GuidelinesfatigueMusculoskeletalrituximabsiccaSjogren's

Would Legalizing Medical Marijuana Help Curb the Opioid Epidemic?

Ronnie Cohen  |  March 28, 2017

(Reuters Health)—In states that legalized medical marijuana, U.S. hospitals failed to see a predicted influx of pot smokers, but in an unexpected twist, they treated far fewer opioid users, a new study shows. Hospitalization rates for opioid painkiller dependence and abuse dropped on average 23% in states after marijuana was permitted for medicinal purposes, the…

Filed under:AnalgesicsDrug Updates Tagged with:DrugsmarijuanaOpioid abuseOpioids

Ustekinumab Has Longer Efficacy Duration than TNFIs for Plaque Psoriasis

Michele B. Kaufman, PharmD, BCGP  |  March 28, 2017

When compared with TNFIs, ustekinumab demonstrated a longer drug survival rate in patients with severe plaque psoriasis…

Filed under:Biologics/DMARDsDrug Updates Tagged with:biologic drugsdrug survivalplaque psoriasisustekinumab

Republicans Revamp U.S. Health Bill, Boost Benefits to Older Americans

Susan Cornwell & Valerie Volcovici  |  March 21, 2017

WASHINGTON (Reuters)—U.S. House Republicans are working on changes to their healthcare overhaul bill to provide more generous tax credits for older Americans and add a work requirement for the Medicaid program for the poor, House Speaker Paul Ryan (R-Wis.) said on Sunday. Ryan said Republican leaders still planned to bring the healthcare bill to a…

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Affordable Care Act (ACA)Health InsuranceMedicaidMedicare

Draft Criteria for ANCA-Associated Vasculitis Released

Susan Bernstein  |  March 20, 2017

WASHINGTON, D.C.—Rheumatologists do not have up-to-date diagnostic and classification criteria for vasculitis, a group of diseases that involves inflammation of the blood vessels, said experts speaking at the 2016 ACR/ARHP Annual Meeting session, Classification Criteria for ANCA-Associated Vasculitis. The most recent classification criteria were published by the ACR in 1990, and since then, new disease…

Filed under:ConditionsMeeting ReportsVasculitis Tagged with:2016 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)ANCAcriteriaDiagnosisDiagnostic and Classification Criteria in Vasculitis Studyrheumatologistupdate

Clinical Trial Data Provides Insight into Muscle Biology, Myositis, Myopathies

Mary Beth Nierengarten  |  March 20, 2017

WASHINGTON, D.C.—Ongoing investigation into the disease mechanisms of inflammatory myopathies is generating needed information for the development of potential future therapeutic targets, and current data from clinical trials have shed light on myopathy concerns in different cohorts of patients. These issues were all discussed in a session titled Muscle Biology, Myositis, and Myopathies I during…

Filed under:ConditionsMeeting ReportsMyositisOther Rheumatic ConditionsResearch Rheum Tagged with:2016 ACR/ARHP Annual MeetingAmerican College of Rheumatology (ACR)anti-synthetase syndromeClinicaldataInflammatory DiseasemuscleMyopathiesmyositisResearchRheumatic Diseasestudy

  • « Previous Page
  • 1
  • …
  • 187
  • 188
  • 189
  • 190
  • 191
  • …
  • 323
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences